Clinical Trials Browser

Phase 1 × Completed × Solid Tumor × Clear all

NCT04158336 2026-03-18

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05735366 2026-03-10

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04617314 2026-01-06

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05109832 2025-09-16

A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05391048 2025-09-16

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05323045 2025-07-09

A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT07030439 2025-06-22

A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT07019194 2025-06-13

An Bioequivalence Study to Compare 10mg & 20mg of Senaparib Capsules in Healthy Chinese Subjects Under Fasting Condition

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02454010 2025-04-04

A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT01585623 2025-03-05

Drug Interaction Study of SAR302503 in Patients With Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT06258330 2025-01-28

Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05176509 2025-01-06

A Study to Evaluate the Combination of YH003, YH001 and Pembrolizumab in Subjects with Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05357820 2024-11-21

A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05357911 2024-11-21

A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03994211 2024-10-26

Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer

Phase 1 Completed

25 enrolled 33 charts

Other solid neoplasm

Solid Tumor

NCT04366648 2024-09-04

Safety, Tolerability and Pharmacokinetics of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05088070 2024-08-30

Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04410224 2024-07-10

ASN004

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04403308 2024-05-03

ONO-7913 Phase I Study (ONO-7913)

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT00921336 2024-04-25

Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05173792 2024-04-25

Study of AK119 in Subjects With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04557306 2024-04-08

Evaluationn of Tolerability and Safety of CBT101, an Autologous Natural Killer Cell, in Patients With Solid Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05547906 2024-03-13

Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05248074 2024-02-20

To Evaluate the Safety, Pharmacokinetic and the Effect of Food After Administration of ABN401 in Healthy Adult Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04862767 2024-01-31

TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04235101 2024-01-05

Phase I Study of SYD985 With Niraparib in Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03099109 2023-10-17

A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02718911 2023-10-16

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

Phase 1 Completed

72 enrolled 23 charts

Other solid neoplasm

Solid Tumor

NCT02959619 2023-08-21

Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK

Phase 1 Completed

Other solid neoplasmThoracic

Solid Tumor

NCT03990454 2023-08-18

Safety Study of SLC-391 in Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05046808 2023-06-08

Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05336279 2023-05-18

Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting Condition

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02278250 2023-03-16

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Phase 1 Completed

97 enrolled 77 charts

Other solid neoplasm

Solid Tumor

NCT05230290 2023-02-06

Clinical Study of KD6001 in Advanced Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04202705 2023-01-30

A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate SYD1875

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03051477 2022-12-08

Trial of Mistletoe Extract in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05440006 2022-09-08

A Study of Food Effect on the Pharmacokinetics of Fuzuloparib Capsules in Chinese Healthy Adult Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03642834 2022-07-06

Study of ICP-105 in Solid Tumors Patients

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03916094 2022-05-05

Evaluate Safety, Tolerability and Pharmacokinetics of HLX22 in Patients With Advanced Solid Tumors Overexpressing HER2

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04035473 2022-04-13

A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel

Phase 1 Completed

42 enrolled 21 charts

Other solid neoplasm

Solid Tumor

NCT02250157 2022-02-22

A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03987685 2022-02-16

Evaluate Oral Topotecan With HM30181A Monotherapy in Patients With Advanced Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03015324 2022-01-25

Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT01004861 2022-01-04

Safety Study of PLX108-01 in Patients With Solid Tumors

Phase 1 Completed

132 enrolled 28 charts

Other solid neoplasm

Solid Tumor

NCT04508179 2021-11-02

A Phase 1 SAD and MAD Study of the Safety, Tolerability and PK of 7HP349 in Normal Healthy Male Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03009292 2021-09-28

Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02730481 2021-09-13

A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03057145 2021-09-02

Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04351165 2021-08-24

BA Study of IMP4297 (20mg vs 10mg) in Healthy Male Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT04584515 2021-08-24

IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers

Phase 1 Completed

Other solid neoplasm

Solid Tumor